NASDAQ:PDSB | Free Cash Flow | PDS Biotechnology Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.37M
2025-12-31-$3.7M$0.00-$3.7M
2025-03-31-$9.03M
2024-12-31-$8.23M$0.00-$8.23M
2024-03-31-$9.94M
2023-12-31-$8.46M$0.00-$8.46M
2023-03-31-$13.19M
2022-12-31-$7.53M
2022-03-31-$6.37M
2021-12-31-$4.5M
2021-03-31-$3.8M
2020-12-31-$4.63M
2020-03-31-$3.16M
2019-12-31-$5.52M
2019-03-31-$3.37M
2018-12-31-$317,628.00$0.00-$317,628.00
2018-03-31-$404,338.00$0.00-$404,338.00
2017-12-31-$9.24M$27,970.00-$9.27M
2017-03-31-$10.77M$89,284.00-$10.86M
2016-12-31-$6.05M$347,295.00-$6.39M
2016-03-31-$9.07M$77,287.00-$9.15M
2015-12-31-$6.78M$505,662.00-$7.29M
2015-03-31-$4.27M$86,078.00-$4.35M
2014-12-31-$2.88M$619,643.00-$3.5M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$27.75M$0.00-$27.75M
2024-12-31-$35.03M$29,000.00-$35.06M
2023-12-31-$33.64M$0.00-$33.64M
2022-12-31-$25.71M
2021-12-31-$12.49M
2020-12-31-$13.15M
2019-12-31-$18.07M
2018-12-31-$1.57M$0.00-$1.57M
2017-12-31-$40.7M$188,721.00-$40.89M
2016-12-31-$32.19M$686,705.00-$32.88M
2015-12-31-$21.75M$1.31M-$23.06M
2014-12-31-$9.72M$884,793.00-$10.6M
2013-12-31-$8.04M$136,894.00-$8.18M